Jacob Schachter

  • 7075 Citations
  • 31 h-Index
1986 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Melanoma Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Adoptive Transfer Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Cell- and Tissue-Based Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1986 2019

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Larkin, J., Brown, M. P., Arance, A. M., Hauschild, A., Queirolo, P., Vecchio, M. D., Ascierto, P. A., Krajsová, I., Schachter, J., Neyns, B., Garbe, C., Sileni, V. C., Mandalà, M., Gogas, H., Espinosa, E., Hospers, G., Lorigan, P., Nyakas, M., Guminski, A., Liszkay, G. & 5 othersRutkowski, P., Miller, W., Donica, M., Makrutzki, M. & Blank, C., Jan 1 2019, In : European Journal of Cancer. 107, p. 175-185 11 p.

Research output: Contribution to journalArticle

Multicenter Studies
Melanoma
Safety
Mutation
PLX4032

ADAR1-mediated regulation of melanoma invasion

Nemlich, Y., Baruch, E. N., Besser, M. J., Shoshan, E., Bar Eli, M., Anafi, L., Barshack, I., Schachter, J., Ortenberg, R. & Markel, G., Dec 1 2018, In : Nature communications. 9, 1, 2154.

Research output: Contribution to journalArticle

RNA Editing
Melanoma
Transcription Factors
RNA
Tissue
16 Citations
Melanoma
Placebos
Mutation
Disease-Free Survival
Keratoacanthoma
2 Citations

Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006

Hamid, O., Robert, C., Ribas, A., Hodi, F. S., Walpole, E., Daud, A., Arance, A. S., Brown, E., Hoeller, C., Mortier, L., Schachter, J., Long, J., Ebbinghaus, S., Ibrahim, N. & Butler, M., Sep 11 2018, In : British journal of cancer. 119, 6, p. 670-674 5 p.

Research output: Contribution to journalArticle

Melanoma
Disease-Free Survival
pembrolizumab
Survival
ipilimumab

Clinical significance of pancreatic atrophy induced by immune-checkpoint inhibitors: A case–control study

Eshet, Y., Baruch, E. N., Shapira-Frommer, R., Steinberg-Silman, Y., Kuznetsov, T., Ben-Betzalel, G., Daher, S., Gluck, I., Asher, N., Apter, S., Schachter, J., Bar, J., Boursi, B. & Markel, G., Dec 1 2018, In : Cancer Immunology Research. 6, 12, p. 1453-1458 6 p.

Research output: Contribution to journalArticle

Exocrine Pancreatic Insufficiency
Atrophy
Case-Control Studies
Colitis
Diarrhea